Whole-body muscle MRI characteristics of LAMA2-related congenital muscular dystrophy children: An emerging pattern

Bönnemann, 2014, Diagnostic approach to the congenital muscular dystrophies, Neuromuscul Disord, 24, 289, 10.1016/j.nmd.2013.12.011 Incecik, 2015, Merosin-negative congenital muscular dystrophy: report of five cases, J Pediatr Neurosci, 10, 346, 10.4103/1817-1745.174432 Zambon, 2020, LAMA2-related muscular dystrophy: natural history of a large pediatric cohort, Ann Clin Transl Neurol, 7, 1870, 10.1002/acn3.51172 Cejas, 2017, Muscle MRI in pediatrics: clinical, pathological and genetic correlation, Pediatr Radiol, 47, 724, 10.1007/s00247-016-3777-6 Quijano-Roy, 2013, Merosin deficient CMD, 179 Fu, 2016, Target” and “sandwich” signs in thigh muscles have high diagnostic values for collagen VI-related myopathies, Chin Med J (Engl), 129, 1811, 10.4103/0366-6999.186638 Carlier, 2019, Myoimaging in congenital myopathies, Semin Pediatr Neurol, 29, 30, 10.1016/j.spen.2019.03.019 Yin, 2019, T2 mapping and fat quantification of thigh muscles in children with Duchenne muscular dystrophy, Curr Med Sci, 39, 138, 10.1007/s11596-019-2012-8 Li, 2015, Progression and variation of fatty infiltration of the thigh muscles in Duchenne muscular dystrophy, a muscle magnetic resonance imaging study, Neuromuscul Disord, 25, 375, 10.1016/j.nmd.2015.01.003 Polavarapu, 2016, Muscle MRI in Duchenne muscular dystrophy: evidence of a distinctive pattern, Neuromuscul Disord, 26, 768, 10.1016/j.nmd.2016.09.002 Leung, 2015, Whole-body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophy, Muscle Nerve, 52, 512, 10.1002/mus.24569 Gerevini, 2016, Muscle MRI findings in facioscapulohumeral muscular dystrophy, Eur Radiol, 26, 693, 10.1007/s00330-015-3890-1 Leung, 2017, Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review, J Neurol, 264, 1320, 10.1007/s00415-016-8350-6 Fatehi, 2017, Long-term follow-up of MRI changes in thigh muscles of patients with Facioscapulohumeral dystrophy: a quantitative study, PLoS ONE, 12, 10.1371/journal.pone.0183825 Schramm, 2013, Whole-Body MRI for evaluation of the entire muscular system, 55 Díaz-Manera, 2015, Muscle MRI in muscular dystrophies, Acta Myol, 34, 95 Fischer, 2008, Distinct muscle imaging patterns in myofibrillar myopathies, Neurology, 71, 758, 10.1212/01.wnl.0000324927.28817.9b Rehmann, 2020, Diffusion tensor imaging reveals changes in non-fat infiltrated muscles in late onset Pompe disease, Muscle Nerve, 62, 541, 10.1002/mus.27021 Liang, 2017, Muscle MRI findings in a one-year-old girl with merosin-deficient congenital muscular dystrophy type 1A due to LAMA2 mutation: a case report, Biomed Rep, 7, 193, 10.3892/br.2017.935 Fahmy, 2018, Whole-body muscle magnetic resonance imaging characteristics of children with merosin-deficient congenital muscular dystrophy, Dev Med Child Neurol, 60, 94, 10.1111/dmcn.29_14018 Fahmy, 2021, Whole-body muscle magnetic resonance imaging characteristics of children with merosin-deficient congenital muscular dystrophy [Poster presentation]. Transformative Journeys. (2018, October 9-13); Tordjman, 2018, Muscular MRI-based algorithm to differentiate inherited myopathies presenting with spinal rigidity, Eur Radiol, 28, 5293, 10.1007/s00330-018-5472-5 Tasca, 2014, Upper girdle imaging in facioscapulohumeral muscular dystrophy, PLoS ONE, 9, 10.1371/journal.pone.0100292 Mercuri, 2007, Muscle MRI in inherited neuromuscular disorders: past, present, and future, J Magn Reson Imaging, 25, 433, 10.1002/jmri.20804 Bing, 2016, Semi-quantitative assessment of lower limb MRI in dystrophinopathy, Int J Clin Exp Med, 9, 13723 Brogna, 2020, MRI patterns of muscle involvement in type 2 and 3 spinal muscular atrophy patients, J Neurol, 267, 898, 10.1007/s00415-019-09646-w Otto, 2020, Quantitative MRI of skeletal muscle in a cross-sectional cohort of patients with spinal muscular atrophy types 2 and 3, NMR Biomed, 33, e4357, 10.1002/nbm.4357 Mercuri, 2005, Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures, Neuromuscul Disord, 15, 164, 10.1016/j.nmd.2004.10.008 Fischer, 2005, Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs, J Neurol, 252, 538, 10.1007/s00415-005-0684-4 Barp, 2020, European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A), J Neurol, 267, 45, 10.1007/s00415-019-09539-y Allamand, 2011, ColVI myopathies: where do we stand, where do we go?, Skelet Muscle, 1, 30, 10.1186/2044-5040-1-30 Sugie, 2015, Characteristic MRI findings of upper limb muscle involvement in myotonic dystrophy type 1, PLoS ONE, 10, 10.1371/journal.pone.0125051 Heskamp, 2019, Lower extremity muscle pathology in myotonic dystrophy type 1 assessed by quantitative MRI, Neurology, 92, e2803, 10.1212/WNL.0000000000007648 Salim, 2020, Characteristic muscle signatures assessed by quantitative MRI in patients with Bethlem myopathy, J Neurol, 267, 2432, 10.1007/s00415-020-09860-x Ropars, 2020, Muscle MRI: a biomarker of disease severity in Duchenne muscular dystrophy? A systematic review, Neurology, 94, 117, 10.1212/WNL.0000000000008811 Naarding, 2020, MRI vastus lateralis fat fraction predicts loss of ambulation in Duchenne muscular dystrophy, Neurology, 94, e1386, 10.1212/WNL.0000000000008939 Leung, 2020, Longitudinal functional and imaging outcome measures in FKRP limb-girdle muscular dystrophy, BMC Neurol, 20, 196, 10.1186/s12883-020-01774-5 Willis, 2013, Quantitative muscle MRI as an assessment tool for monitoring disease progression in LGMD2I: a multicentre longitudinal study, PLoS ONE, 8, e70993, 10.1371/journal.pone.0070993 Chu, 2018, The limb-girdle muscular dystrophies: is treatment on the horizon?, Neurotherapeutics, 15, 849, 10.1007/s13311-018-0648-x Babačić, 2019, CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: a systematic review, PLoS ONE, 14, 10.1371/journal.pone.0212198